{
    "nctId": "NCT05961280",
    "briefTitle": "Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates",
    "officialTitle": "Upstaging and Lymph Node Metastasis Rate in Patients With Ductal Carcinoma in Situ Who Received Mastectomy Regarding the Necessary of Sentinel Lymph Node Biopsy",
    "overallStatus": "COMPLETED",
    "conditions": "Ductal Carcinoma in Situ",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 385,
    "primaryOutcomeMeasure": "Axillary lymph node metastasis rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women diagnosed with DCIS in preoperative biopsy samples obtained by core needle biopsy, vacuum-assisted breast biopsy, or excisional biopsy\n2. Women underwent curative surgery for DCIS\n\nExclusion Criteria:\n\n1. Patients who received breast-conserving surgery\n2. Patients who had concurrent contralateral invasive breast cancer\n3. Patients who were in case of ipsilateral breast tumor recurrence\n4. Patients whose invasiveness was uncertain in the biopsy samples",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}